TDA has been stating the same thing. That seems to be what the company is signaling.
I would suspect that we are nearing a product ramp so the company can now issue some real guidance.
R&D fell from around 16MM for 4Q FY15 to 10.7MM 2Q FY 16 so at least we know their getting the cost down. With some product ramp more expense can be moved out of R&D and recaptured through Cost of Revenue.
Compare Insulets (PODD) with UNS's SG&A expense. Our CFO has commented that our SG&A, being we are a BtoB model, is highly leverage-able. Comparing UNS to PODD he is not kidding.
UNS Price at posting:
13.0¢ Sentiment: Buy Disclosure: Held
